Open Access 01.12.2025 | Research
The effectiveness of dyadic interventions for health outcomes of prostate cancer patients and informal caregivers: a systematic review and meta-analysis
Erschienen in: BMC Nursing | Ausgabe 1/2025
Abstract
Background
Prostate cancer is a worldwide health issue, and current prostate cancer care extends to the patient‒caregiver dyadic setting, where individuals are interdependent and interact with each other as well as possible negative psychological and behavioural outcomes. However, the impact of dyadic care interventions on health outcome indicators for prostate cancer patients and their informal caregivers has yet to be examined.
Aim
To describe the characteristics of dyadic interventions involving patients with prostate cancer and their informal caregivers and investigate their effects on psychosocial health, sexual health, and dyadic relationships.
Methods
Ten electronic databases (Web of Science, Cochrane Library, PsycINFO, PubMed, Embase, CINAHL, CNKI, Wanfang, VIP, and SinoMed) were thoroughly searched for related publications published between the database’s founding and April 2024. The risk of bias for the included studies was evaluated using the Cochrane risk-of-bias tool, and a meta-analysis was performed using RevMan 5.4.
Results
This study identified and evaluated 19 RCTs reporting 22 different interventions, as well as outcome indicators for the three aspects of psychosocial health, sexual health, and dyadic relationships in prostate cancer patients and informal caregivers. A meta-analysis of pooled data revealed that for prostate cancer patients, the intervention improved dyadic coping (SMD95% CI [95% CI] = 0.22 [0.01;0.42], p = 0.04), and for informal caregivers the dyadic care intervention reduced anxiety (SMD95% CI [95% CI] = -0.35 [-0.65;-0.06], p = 0.02), enhanced self-efficacy (SMD [95% CI] = 0.22 [0.01;0.43], p = 0.04), and improved sexual functioning (SMD [95% CI] = 0.29 [0.05;0.54], p = 0.02). No statistically significant overall effects were observed for the other outcome indicators.
Conclusion
The results of this review indicate that dyadic care interventions benefit prostate cancer patients and informal caregivers. However, given features such as research quality and sample size, further randomized controlled trials with excellent study designs are needed in the future to evaluate and validate the efficacy of dyadic care treatments for patients with prostate cancer.
Trial registration
The protocol for this study is registered in PROSPERO with registration number (CRD42024567542).
Prostate cancer represents a significant public health challenge and is a leading contributor to illness and death among men across the globe; it ranks as the second most prevalent cancer in men, with approximately 1,414,000 new cases and 375,304 deaths recorded globally in 2020 [1]. Earlier diagnoses, increased treatment outcomes, and longer life expectancies, coupled with the greater prevalence of prostate cancer in older men, mean that the proportion of men being diagnosed and treated for prostate cancer will continue to rise in the foreseeable future. This trend has concerning consequences for patients’ overall well-being, including a heightened risk of metabolic disease and diminished quality of life [2, 3], many of which are linked to the treatments received. Throughout the illness, starting with the diagnostic assessment, patients commonly cope with cancer in the company of at least one caregiver while dealing with visits and appointments, side effects of treatment, changes in daily routines, and enduring considerable distress, all of which increase the need for caregivers.
Informal caregivers, who include friends and family members, are usually the main sources of care for men suffering from prostate cancer. Informal caregivers are individuals who have some relationship with the person being cared for; they are primarily responsible for providing care, emotional support, and financial support; they can be relatives, friends, partners, or neighbours, and they are usually neither trained in professional knowledge nor paid [4, 5]. Informal caregivers help alleviate health care system demands and contribute positively to patients’ adjustment to illness. However, caregiving behaviours can negatively influence caregivers’fitness, affecting their mental and physical wellness, health-associated quality of life (QOL), and relationship satisfaction. There is strong evidence that caregivers of people with prostate cancer have poorer mental health than the average person, with greater percentages of anxiety and depression diagnoses and high levels of caregiving stress [6]. In addition, caregivers have reported several ongoing physical challenges: problems with sleep, exhaustion, discomfort, absence of muscle strength, decreased desire for food, and weight gain [7]. Conversely, caregivers’problems are closely linked with patients’well-being, so early interventions that focus on how prostate cancer patients and informal caregivers cope with symptoms and consequences of the disease are critical.
Anzeige
In the past few decades, several types of interventions have been developed that target multiple outcome indicators. However, most interventional studies have tended to be limited to prostate cancer patients or their caregivers. For example, numerous studies have indicated that various psychosocial interventions for prostate cancer patients may alleviate feelings of depression or anxiety [8, 9] and increase their quality of life [10]. However, because cancer, as a codependent system, affects both patients and their caregivers and can lead to various physical and mental disorders during the course of the illness, the main concern related to cancer treatment and research has changed from a focus on one person to the patient–caregiver dyad [11]. Many approaches have been developed to assist patients and caregivers dealing with cancer as dyads.
In recent years, several systematic reviews of dyadic interventions for cancer patients have been published; however, these reviews included all cancer types and lacked cancer population specificity. In addition, Chen et al. [12] and Shen et al. [13] conducted systematic reviews and meta-analyses, respectively, and examined the results as they relate to the standard of life or emotional wellness of prostate cancer patient–spouse dyads. However, prostate cancer is often regarded as a “relational cancer”, a type of disease in which caregiver engagement may be required for certain therapeutic options that generally involve the areas of intimacy and procreation. Moreover, many physical and psychological challenges, such as urinary and bowel incontinence, sexual dysfunction, fatigue, and psychological distress, pose a threat to couples’ relationships and intimate experiences [14, 15]. Lyons and Lee’s dyadic illness management theory [16] states that a dyad’s health practices and outcomes are mutually reliant.
To provide current evidence for successful approaches to dyadic care interventions, this study aimed to (1) describe the characteristics of various interventions and (2) investigate the impact of interventions on psychosocial health, sexual health, and relationships with dyads of people with prostate cancer and their caregivers.
This systematic review and meta-analysis were reported as per the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines to ensure a transparent and comprehensive report of the review, and the study protocol has been registered in PROSPERO (registration number CRD42024567542).
Anzeige
Ten electronic databases (Web of Science, Cochrane Library, PsycINFO, PubMed, Embase, CINAHL, CNKI, Wanfang, VIP, and SinoMed) were thoroughly searched for related publications published between the database’s founding and April 2024. The following keywords and MeSH subject headings were applied: (prostatic neoplasms OR prostate neoplasms) AND (caregivers OR spouse OR wife) AND (intervention OR therapy OR exercise) AND (randomized controlled trial). Table S1 in the Additional file 1 contains specific information on the search approach. We also manually reviewed relevant reviews and reference lists to find and obtain other papers.
The inclusion criteria were as follows: (1) Study population: (a) patients with a confirmed diagnosis of prostate cancer and ≥ 18 years of age. (b) caregivers: informal caregivers; ≥18 years old. (2) Interventions: included interventions based on patients with prostate cancer and their informal caregivers. (3) Controls: any control group. (4) Outcome metrics: included health outcomes for prostate cancer patients and caregivers informally. (5) Study type: randomized controlled trial. (6) Language: Chinese or English were used in the published version of the study.
The exclusion criteria were as follows: (1) conference abstracts, reviews, theses, study protocols, and duplicate reports, and (2) studies that did not have relevant data.
Two reviewers independently scrutinized the collected articles’ titles and abstracts for relevance and then compared the screening results to reach a consensus. The two reviewers independently reviewed the full texts of potentially relevant articles according to the selection criteria, and the selection was made by a consensus. Any remaining issues related to publication selection were settled by a third reviewer.
One reviewer gathered data from the listed studies and combined them into a Microsoft Excel file. Another reviewer independently verified the accuracy of the extracted data. The following data were extracted from the included studies: (1) study information, such as first author, year of publication, and country; (2) characteristics of patients and caregivers with prostate cancer (sample size and mean age); (3) interventions (process of the intervention, provider, content, duration, and frequency) and control measures; and (4) outcome metrics (duration of follow-up).
The risk of bias for the included studies was evaluated via the Cochrane risk-of-bias tool [17] recommended by the Cochrane Collaboration. Information was retrieved from the articles regarding random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. Disagreements were settled by discussion or consultation with a third author.
A meta-analysis was performed using RevMan 5.4. The standardized mean difference (SMD) was calculated for the outcome indicators using different measurement tools, and the 95% CI was calculated for each effect size. Pooling of data from individual RCTs was conducted to obtain overall effects estimates and 95% CIs with the random-effects model (I2 > 50%) or fixed-effects model (I2 ≤ 50%) [18], and P < 0.05 was considered statistically significant. In addition, this analysis revealed publication bias via funnel plots [19], and a subgroup analysis was carried out from two perspectives, namely, duration (< 3 months, ≥ 3 months) and delivery method (offline, e-health, or mixed methods). A sensitivity analysis was conducted using the “remove one study”approach to evaluate the influence of each study on the overall effect size [20].
A total of 7321 records were generated from the 7317 records searched in the database plus the 4 records manually searched. Of these, 2014 remained after the deletion of duplicates, of which 5128 were excluded after screening the titles and abstracts. After the full texts of the remaining 169 records were reviewed, a total of 19 randomized controlled trials were ultimately included in this study (Fig. 1).
Fig. 1
PRISMA flow diagram of the study selection process
×
Between 2004 and 2022, 19 studies were published, most of which originated in the USA (n = 8), followed by the UK (n = 3) and China (n = 3), with fewer studies originating from other countries. Table S2 in Additional file 1 presents the specifics of each study.
Anzeige
The total sample size for the study comprised 17 [21] to 263 [22]pairs, and the patients’ and caregivers’ mean ages ranged from 51.7 to 77.0 years and 50.7 to 75.6 years, respectively. Two of the 19 studies did not report demographic information [21, 23]. In addition, of the relationships between patients and caregivers, 14 studies reported spousal or cohabiting relationships [21, 22, 24‐35], and 3 reported relationships limited to legal heterosexual couples [36‐38].
Nineteen studies involved twenty-two varied interventions. Nurses delivered the majority of interventions (n = 8) [22, 25, 26, 35‐39], and in three of these interventions the care providers also involved sports coaches, counsellors [39], doctors [36] or researchers, psychotherapists, and nurse practitioners [37]. The interventions in two studies required participants to complete the intervention on their own by logging on to a specific website provided by the researcher [33, 34].
The included studies described multiple modes of intervention delivery. In ten studies, interventions were delivered via conference or course [21‐24, 27, 29‐32, 39], with 2 studies also involving the provision of information materials, a holistic needs assessment, and a personalized self-management care plan [39] or reading of a brochure. In 6 studies [25, 26, 28, 35‐37], the intervention was delivered in the form of counselling, with 2 studies also involving the mailing of an information brochure or the delivery of a multimedia film [26] via an app or in conjunction with Pelvic Floor Muscle Training (PFMT) [28]; in the other studies (n = 3), the intervention was delivered by having participants log on to a specific website, such as TrueNTH [33], TEMPO [34] or ESCP [38], on their own.
All participants but 1 in the control group used Survivorship Care Plans (SCP) [38]. The remaining 18 studies used standard care or usual care.
Each study measured at least one outcome, including psychosocial health, sexual health, or an outcome related to dyadic relationships. For prostate cancer patients, the following ten outcomes were included in this study: psychosocial health (quality of life, neuropsychiatric symptoms, anxiety, depression, stress, self-efficacy), sexual health (sexual function, sexuality-related mental health), and dyadic relationships (relationship satisfaction, dyadic coping). For caregivers, the following nine outcomes were included: psychosocial health (quality of life, neuropsychiatric symptoms, anxiety, depression, stress, self-efficacy), sexual health (sexual function), and dyadic relationships (relationship satisfaction, dyadic coping). Other outcomes were not included in further analyses because they were reported in fewer than three studies.
Among the 19 studies, 1 (5.2%) [26]had a low risk of bias; 5 (26.3%) [25, 27, 28, 32, 37] were judged to be have a high risk, mainly because they did not report on or blind participants and personnel; and the remaining 13 (68.4%) [21‐24, 29‐31, 33‐36, 38, 39] had “some concerns”. For the other three domains (random sequence generation, allocation concealment, and blinding of outcome assessment), 5–12 of the 19 studies were rated as having “some concerns”. Thirteen studies [23, 25‐34, 36, 39] were rated as having “low” risk because of the provision of sufficient evidence on the randomization process. In terms of allocation concealment, 7 studies [21, 25‐28, 31, 38] were assessed as “low” risk because of sufficient details of the implementation of allocation concealment, such as the use of sequential numbering or sealed envelopes, and 9 studies [22, 26, 32‐34, 36‐39] were assessed as “low” risk due to blinding study outcomes. The results of the risk of bias for the included studies are shown in Figs. 2 and 3.
Fig. 2
Summary of risk of bias for included studies
×
Fig. 3
Summary of risk of bias for included studies
×
Anzeige
For the meta-analysis of quality of life in prostate cancer patients, pooled data from 10 studies were used [21, 22, 24, 28, 29, 32, 34, 36, 38, 39]. These studies were heterogeneous (p < 0.00001, I2 = 93%), and a subgroup analysis revealed that patients’ quality of life was not significantly affected by the duration of the intervention (< 3 months: SMD95% CI [95% CI] = 0.62 [-0.09;1.34], p = 0.09; ≥3 months: SMD95% CI [95% CI] =-0.15 [-0.56;0.25], p = 0.46) (Figure S1a-1) or the way it was delivered (offline: SMD95% CI [95% CI] = 0.08 [-0.17;0.33], p = 0.53; e-Health: SMD95% CI [95% CI] = 0.16 [-0.19;0.51], p = 0.37; mixed methods: SMD95% CI [95% CI] =-2.16[-4.63;0.32], p = 0.09) (Figure S1a-2).
The overall outcomes revealed that there was no meaningful change in the neuropsychiatric symptoms of patients (SMD95% CI [95% CI] = -0.09 [-0.44;0.25], p = 0.59) (Figure S1b) or caregivers (SMD95% CI [95% CI] = -0.86 [-2.23;0.50], p = 0.22) (Figure S2b). Furthermore, because all included studies had intervention durations of less than 3 months, subgroup analyses were not possible for both.
Five studies evaluated how an intervention affects patients’ anxiety [28, 31, 34, 36, 39]. However, the combined results (Figure S1c) demonstrated high heterogeneity (p < 0.00001, I2 = 87%) and no intervention impact (SMD95% CI [95% CI] = -0.41 [-1.18;0.36], p = 0.30).
The impact of the intervention on caregivers’ anxiety was examined in five investigations [24, 28, 31, 34, 36]. The combined results (Figure S2c) revealed that the overall effect was statistically significant for anxiety (SMD95% CI [95% CI] = -0.35 [-0.65;-0.06], p = 0.02). Subgroup analyses revealed that intervention durations of less than three months (SMD95% CI [95% CI] = -0.50 [-0.87;-0.14], p = 0.007) (Figure S2c-1) and forms of intervention delivered through mixed methods (SMD95% CI [95% CI] = -0.51 [-0.92;-0.10], p = 0.01) (Figure S2c-2) were effective in reducing caregiver anxiety.
Six studies reported depression scores from prostate cancer patients [28, 30, 31, 34, 36, 39], and six studies reported depression scores from caregivers [24, 28, 30, 31, 34, 36]. Neither meta-analysis demonstrated an effect of the intervention on depression (patients: SMD95% CI [95% CI] = -0.21 [-0.68;0.26], p = 0.38; caregivers: SMD95% CI [95% CI] = -0.22 [-0.54;0.10], p = 0.18) (Figure S1d) (Figure S2d), and it is crucial to acknowledge that these studies had substantial heterogeneity (patients: p < 0.00001, I2 = 84%; caregivers: p = 0.02, I2 = 60%).
Among the included studies, only 3 investigated the impact of interventions on patient stress [27, 29, 30] (Figure S1e). The change in both groups of participants was not statistically significant (SMD95% CI [95% CI] = -0.02 [-0.21;0.16], p = 0.80). Only 2 studies investigated the effect of the intervention on caregiver stress [27, 30], and the results revealed no effect of the intervention (SMD95% CI [95% CI] = -0.17 [-0.39;0.05], p = 0.14) (Figure S2e).
Seven studies reported self-efficacy scores provided by prostate cancer patients [21, 22, 24, 28, 34, 38, 39] (Figure S1f). In contrast to the control group, the dyadic interventions failed to enhance patient self-efficacy in the intervention group (SMD95% CI [95% CI] = 0.04 [-0.15;0.23], p = 0.67) (Figure S1f).
Five studies reported self-efficacy ratings from caregivers [21, 22, 28, 34, 38] (Figure S2f), with low heterogeneity between studies (P = 0.20, I2 = 33%); caregivers in the intervention group outperformed those in the control group with respect to improving self-efficacy, with a statistically significant difference (SMD95% CI [95% CI] = 0.22 [0.01; 0.43], p = 0.04) (Figure S2f). Notably, interventions that lasted less than three months were related to increased caregiver self-efficacy (SMD95% CI [95% CI] = 0.28 [0.03;0.52], p = 0.03) (Figure S2f-1).
Only three of the included studies reported on sexuality-related mental health outcome indicators for patients [25, 28, 31] (Figure S1h). The intervention group’s total effect did not show any substantial benefit (SMD95% CI [95% CI] = -0.05 [-0.29;0.20], p = 0.71), and subgroup analyses could not be performed because the duration of the intervention was greater than 3 months in all three studies. No studies have reported on sexuality-related mental health outcomes for caregivers.
Four included studies, involving six different interventions [25, 28, 30, 37], assessed the impact of interventions on relationship satisfaction in patients (Figure S1i), and the heterogeneity test revealed substantial heterogeneity among the studies (P < 0.0001, I2 = 82%). To explore the heterogeneity, a subgroup analysis by intervention was performed. The results indicated that an intervention in the form of offline delivery increased patients’ relationship satisfaction (offline: SMD95% CI [95% CI] = 1.14 [0.69; 1.59], p < 0.00001); however, neither the duration of the intervention (< 3 months: SMD95% CI [95% CI] = 0.36 [-0.32; 1.04], p = 0.30; ≥3 months: SMD95% CI [95% CI] =-0.21 [-0.47; 0.04], p = 0.10) (Figure S1i-1) nor the other two intervention forms had a significant effect on patient relationship satisfaction (e-Health: SMD95% CI [95% CI] =-0.19 [-0.46; 0.08], p = 0.16; mixed methods: SMD95% CI [95% CI] =-0.04 [-0.26; 0.19], p = 0.75) (Figure S1i-2).
Five studies investigated the effects of treatments on caregiver relationship satisfaction [25, 28‐30, 37] (Figure S2h). The combined results indicate heterogeneity among these studies (P = 0.003, I2 = 70%), and none of the effects of the intervention effects were substantial (SMD95% CI [95% CI] = 0.21 [-0.07;0.49], p = 0.15).
Four studies reported dyadic coping by prostate cancer patients and caregivers [22, 27, 34, 38]; for patients, the findings revealed a statistically significant effect (SMD95% CI [95% CI] = 0.22 [0.01;0.42], p = 0.04) (Figure S1j); however, the intervention did not affect caregivers (SMD95% CI [95% CI] = 0.13 [-0.09;0.34], p = 0.25) (Figure S2i).
The elimination approach was employed to eliminate each study separately. After excluding studies by Yuan et al. [36] and Luo et al. [37], the overall heterogeneity in the literature decreased significantly, e.g., with the I2 for patient quality of life decreasing from 93 to 0%, the I2 for patient satisfaction decreasing from 82 to 0%, and the I2 for caregiver depression decreasing from 60 to 20%, which may be the relevant source of heterogeneity. For the remaining outcomes, the differences in the I2 values after the exclusion of any studies were usually minor, indicating that the meta-analysis results were generally reliable.
Given the few studies included (n < 10), only the quality-of-life outcome in patients with prostate cancer was evaluated for publication bias. The funnel plot shown in Figure S3 of the Additional file 1 indicates that the results showed that the distribution of the studies was generally symmetrical; therefore, the likelihood of publication bias in the included studies was low.
This review identified and evaluated 19 RCTs reporting 22 different interventions by analysing the results of dyadic interventions for people with prostate cancer and their informal caregivers. These RCTs had been published over the past 20 years and included three outcome indicators for patients and caregivers. The majority of the investigations were rated as having a moderate probability of bias, and the findings of all meta-analyses revealed that the overall effect on prostate cancer patients was not related to the intervention on any of the included outcomes except for dyadic coping. In contrast, the intervention was effective on three outcome indicators: caregiver anxiety, self-efficacy, and sexual function. According to the subgroup analyses, caregivers’ anxiety improved, and self-efficacy increased, when the duration of the dyadic intervention was less than 3 months. Subgroup analyses indicated that interventions delivered in an offline format improved patients’ relationship satisfaction; however, when the duration of the dyadic intervention was less than 3 months, caregiver anxiety improved, self-efficacy increased, and mixed forms of dyadic interventions also contributed to reductions in caregiver anxiety. The heterogeneity among the studies in our systematic review may be attributed to several factors. First, variations in study design and methodology, including differences in randomization procedures, blinding, and interventional contents, may account for the observed variability. Second, it is vital to emphasize that the two studies that produced greater heterogeneity were both conducted in developing countries [36, 37] and that the data were more susceptible to variables such as the study’s context of exposure, the region of the included subjects, etc. Compared with other studies that were conducted in countries with large economies, such as the US and the UK, the findings from this study provide evidence to support the impact of the use of dyadic (patient–caregiver) interventions on differential health outcomes for prostate cancer patients as well as caregivers.
A meta-analysis of studies of prostate cancer patients and their informal caregivers revealed no significant effect of dyadic care interventions on health-related quality of life, and the results of this study are consistent with those of previous studies [12]. Many factors contribute to quality of life, including mental, physical, social, and cognitive functioning [40]. On the one hand, the lack of effect of an intervention may be explained by several factors. First, the quality of life of the subjects included in some of the studies had already been assessed in a manner similar to that of the normal population at baseline, so the effect of the intervention was limited [21, 22]. Second, the content of the intervention implemented in the intervention group was broadly similar to that implemented in the control group; e.g., in Song et al.’s study [38] the NCI website used in the control group was similar to that used in the experimental group with the PERC mobile health care app, which had similar information, online chat and support features. In addition, even when standard care was set as the intervention in the control group, some force majeure issues, such as social support and economic levels, had an impact on quality of life [41]. On the other hand, according to some of the intervention studies, several potentially effective intervention mechanisms exist. First, the interventions mostly involved the prior organization of a multidisciplinary team, starting from the existing patient and caregiver problems and explaining the disease and its care to improve their comprehension so that effective measures can be applied to solve the actual problems [42]. Second, intervention processes are often long and monotonous, and including the caregiver in the care plan allows the prostate cancer dyad to empathize with one another and support each other’s coping, improving adherence to the intervention and quality of life [42]. Third, the intervention builds a relaxing atmosphere through empathy, communication, assistance, and attention from health care professionals to patients and caregivers, showing concern and professionalism and improving the dyad’s mental health as well as both patients’ and caregivers’ quality of life. Therefore, future dyadic interventions should incorporate these points to increase the quality of life for men with prostate cancer and their caregivers.
Depression and anxiety are prevalent in men with prostate cancer and lead to a lower quality of life, decreased treatment adherence, and increased mortality. Their caregivers are often more distressed than the patients are, and exhibit rates of major depression. The prevalence of generalized anxiety disorders may be up to twice as high as that in the general population and may remain elevated long after treatment [43‐46]. In line with previous findings [13], the intervention had no significant effect on depression in prostate cancer patients or caregivers. In contrast, this study revealed that the dyadic intervention significantly improved anxiety in caregivers, whereas no effective improvement in patient anxiety was observed; this is not surprising because patients and caregivers have different support needs. As the primary providers of care activities, caregivers carry a variety of physical, psychological, and financial burdens and face social pressures as well, with subgroup analyses revealing that an intervention duration of < 3 months significantly reduces their anxiety. However, this intervention effect was not sustained, with previous research suggesting that caregivers have more distress than patients do but receive less support [47]. Furthermore, the intervention provided them with information and support that reduced their negative appraisals of caregiving, uncertainty, and feelings of hopelessness and helped them learn how to cope with stress and symptom management. However, because prostate cancer is a ‘relational cancer’, many of the symptoms and sequelae of the disease affect both patients and their carers. In addition, because conventional cancer care or services do not provide sufficient social and family support during subsequent long-term care, the effectiveness of the interventions also change over time. Mixed-method interventions allow caregivers to feel less anxious. Offline interventions, such as conferencing, face-to-face communication, and coaching, are able to foster a more sympathetic connection and identify caretakers’ deeper needs [48, 49]. E-health interventions, in the form of audiovisuals, which take advantage of the internet’s portability and expandability, are capable of laying down information barriers between doctors and patients. A mixed-methods intervention that incorporates both approaches provides for more tailored and comprehensive assistance. Overall, given the aforementioned factors, intervenors should select acceptable formats for delivery methods for informal caregivers based on their characteristics and the circumstances of the scenario. The impact of implementing therapies focused on improving anxiety and depression in patients and their informal caregivers requires further investigation.
Self-efficacy has a powerful influence on a person’s motivation, perseverance, and thought processes and plays an important role in deciding whether to take action, the amount of work to put in, and how often to persevere when faced with obstacles or failures [50]. However, meta-analyses have shown that dyadic interventions do not have a significant impact on self-efficacy in prostate cancer patients. First, the included studies originated in developed countries, where the study population was well educated and well adjusted, making it harder to achieve the desired intervention outcomes. Second, most studies did not include self-efficacy as a primary outcome and therefore did not design targeted intervention modules to improve it. Conversely, the dyadic intervention improved caregivers’ self-efficacy through mechanisms comparable to those that promote other psychosocial outcomes. Future research should focus on study participants who require support and help or add routine care to assess self-efficacy.
As a component of overall health, the World Health Organization defines sexual health as the state of physical, emotional, spiritual, and social well-being related to sexuality [51]. All aspects of sexual health are affected after prostate cancer treatment. Furthermore, most caregivers are postmenopausal women whose sexual function also requires assistance. Sexual dysfunction is one of the most prevalent sexual health issues, and it encompasses not only erectile dysfunction but also impaired arousal and orgasm, with far-reaching consequences for intimacy, communication, and fulfilment in relationships between patients and companions [52]. This meta-analysis revealed three research reports on the consequences of dyadic therapies for patients’ sexual function [25, 28, 33], two of which involved caregivers [25, 33]. The findings did not show an effect of dyadic interventions on the patients but did show an effect on the caregivers. The reasons for this may be include that patients’ distress with penile shortening and erectile and urinary dysfunction limits their desire to engage in sexual activity during recovery, irrespective of the primary type of treatment. Most of the study intervention durations and follow-up times may be premature; previous studies have shown that the mean recovery time for patients whose sexual function returned to baseline levels was 13.2 months [53] and that some patients were not able to regain firmer and more reliable erectile function until 2–4 years after surgery. Given that suppressing emotions and thoughts is not only a coping mechanism but also a means of maintaining relationship continuity, patients and their caregivers often choose to avoid discussing topics related to sexual issues [54]. Interventions related to sexual function have gradually shifted from the early patient-dominant, caregiver-supportive model to one in which both are equal participants in the intervention [55]. The interventions included in the study not only provided pharmacological and surgical treatment for erectile dysfunction but also involved comprehensive psychological and sexual counselling, which has helped them recognize the need for communication, mutual acceptance, and assistance in sexual rehabilitation after prostate cancer care, in turn helping improve sexual function. Due to the limited number of meta-analyses, more high-quality randomized controlled trials could be conducted in the future for prostate cancer patients and their caregivers. The reliability and validity of the intervention results still must be interpreted in conjunction with newly published studies and follow-up work.
Dyadic coping is a process in which both individuals and partners collaborate to maintain or reestablish the balance of mental health, physical health, and the dyadic relationship [56]. In this study, the results of the meta-analysis revealed that the intervention was effective in improving dyadic coping in patients. Communication and obtaining expert direction in interventions can help dyad members develop relationships and self-expression as well as understand each other’s genuine thoughts and emotions and provide encouragement and support. However, prostate cancer affects not only the individual but also the structure and hierarchy of the entire family. Some studies have reported a strong positive correlation between dyadic coping and relationship satisfaction [57], which is the most commonly studied dependent variable in dyadic intervention studies. Given that female caregivers receive less attention and appear to be at greater risk of reduced marital satisfaction than men, reduced marital satisfaction may be of greater concern to prostate cancer patient‒caregiver dyads [43]. Evidence among prostate cancer patients indicates that greater marital satisfaction is linked to patient health several years after treatment [58], as well as with a longer median survival time [59], and that there is a connection between physical health, mental health, and partner relationship satisfaction in couples who have faced prostate cancer. Although meta-analyses have shown that interventions do not have a significant effect on relationship satisfaction, the theory of spousal disclosed intimacy suggests that enhanced dyadic communication has a positive effect on spousal intimacy, as reflected in the results of Luo et al.‘s [37] intervention, which are consistent with the results of a previous intervention on enhancing couple communication to increase relationship satisfaction [60]. Furthermore, the statistically significant findings of this subgroup analysis should be interpreted with caution, because only one trial took the intervention offline. As a result, future dyadic interventions should include caregivers, incorporating communication interventions to help them navigate potential mutual benefits and conducting more studies of higher-quality to provide more conclusive evidence, such as determining appropriate intervention durations and providing enrichment support resources.
This review has important implications for the study of prostate cancer care. In clinical practice, our outcome study reinforces the importance of providing nursing interventions in the context of prostate cancer dyads. In contemporary cancer care in the hospital or at home, it is critical to change from focusing solely on individual interventions to providing full dyadic help that fosters mental and physical health and accomplishes holistic care and optimal recovery for both patients and informal caregivers. Health care professionals should be proactive in targeting both individual and dyadic factors to provide timely and personalized interventions to effectively benefit the prostate cancer dyad.
Anzeige
This study assesses the effectiveness of dyadic care interventions in the field of prostate cancer in improving outcomes related to psychosocial health, sexual health, and dyadic relationships for patients and their informal caregivers; it presents multiple proposals for additional studies in this area. First, caregivers must be included in care plans to better harness, and make numerous suggestions for, additional studies of the potential interplay between patients and their informal caregivers. Caregivers frequently are viewed as external observers or only as care providers. Health care professionals must be aware that caregivers can also be affected by cancer and should view them as coreceivers of care. Ideally, a structured and systematic care plan would help dyads better cope with the effects of cancer. Therefore, further research is needed on cost-effective and efficient care planning for prostate cancer patients and caregivers in busy health care settings. Second, future research on the use of measurement tools, such as assessments of quality of life, could consider the use of both disease-specific and more comprehensive measures of a healthy quality of life. More attention must be paid to other easily overlooked endpoints, such as loneliness, distress, and self-efficacy. Finally, the results of the meta-analysis revealed that the intervention did not have a significant effect on more than half of the outcome indicators; this illustrates, on the one hand, the complexity of dyadic care interventions in the field of prostate cancer and the need for additional studies using broad and high-quality samples to validate the efficacy of care interventions in improving the dyadic care of prostate cancer patients. On the other hand, the best features associated with successful dyadic care treatments found in this research can still be evaluated and employed in future approaches and research with a commitment to exploring the factors that contribute to their potential success.
This review has several limitations. First, although as many studies as possible were included that met the criteria by snowballing through manual searches, we included only studies published in English and Chinese due to language restrictions imposed by the researchers, which may have resulted in missed articles written in other languages. In addition, some studies were excluded because they did not adequately report data and because the authors did not respond to our requests for clarification. Furthermore, the high degree of heterogeneity due to the diversity of studies in terms of country of origin, interventions (modality, frequency, duration), metrics, and time points of measurement, as well as the predominance of studies from high-income countries, may limit the applicability of findings to low- and middle-income countries, highlighting the necessity for further investigation in these contexts. Finally, although subgroup analyses identified intervention designs of varying durations, the small number of studies in every subgroup limits robust comparisons. Given the moderate to serious chance of bias in current studies, there is a need for high-quality evidence on prostate cancer care through rigorous study design.
This review analyses the effectiveness of dyadic care intervention studies of the psychosocial health, sexual health, and dyadic relationships of prostate cancer patients and their informal caregivers. A meta-analysis of three outcome indicators revealed that the dyadic care intervention was effective only for the outcome indicators of patients’ dyadic coping and caregivers’ anxiety, self-efficacy, and sexual function. Despite the limitations of the meta-analysis, it could still offer some insight. Researchers should prioritize methodological quality; provide comprehensive details on random sequence generation and blinded implementation; and perform large-scale, multicentre research. In addition, to examine and confirm the effectiveness of dyadic care interventions, future studies should design more comprehensive intervention programmes with appropriately longer follow-up periods and incorporate the specific needs of dyads.
The authors thank AJE for the language of the document.
Not applicable.
Not applicable.
The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.